1-6 of 6
Brett E. Skolnick
Close
Sort by
Journal Articles

Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects

Clinical Trials & Observations
Brett E. Skolnick, David R. Mathews, Naum M. Khutoryansky, Anthony E. Pusateri, Marcus E. Carr
Journal: Blood
Blood (2010) 116 (5): 693–701.
https://doi.org/10.1182/blood-2009-11-253492
Published: 2010
Journal Articles

Punch Biopsy Model To Evaluate the Impact of Anticoagulation or Antiplatelet Therapy-Induced Bleeding Episodes: Model Validation.

David Mathews, M.D., Naum Khutoryanski, Ph.D, D.Sc., Brett E. Skolnick, PhD
Journal: Blood
Blood (2007) 110 (11): 3157.
https://doi.org/10.1182/blood.V110.11.3157.3157
Published: 2007
Journal Articles

Variations in Ex-Vivo Assessments of Hemostasis.

Don A. Gabriel, MD, Brett E. Skolnick, PhD, Lisa Payne Rojkjaer, MD, Stephanie V. Seremetis, MD
Journal: Blood
Blood (2005) 106 (11): 4052.
https://doi.org/10.1182/blood.V106.11.4052.4052
Published: 2005
Journal Articles

Effect of Recombinant Activated Factor VII (rFVIIa) on Platelet and Clotting Systems in Healthy Volunteers.

Don A. Gabriel, MD, Brett E. Skolnick, PhD, Stephanie Seremetis, MD, Philip Leese, MD, David Mathews, MD
Journal: Blood
Blood (2005) 106 (11): 4053.
https://doi.org/10.1182/blood.V106.11.4053.4053
Published: 2005
Journal Articles

Ex-Vivo Assessments in the Evaluation of Dose Response to Recombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers.

Don A. Gabriel, MD, Brett E. Skolnick, PhD, Philip Leese, MD, David Mathews, MD
Journal: Blood
Blood (2005) 106 (11): 4055.
https://doi.org/10.1182/blood.V106.11.4055.4055
Published: 2005
Journal Articles

Safety of Recombinant Activated Coagulation Factor VII in Non-Hemophilia Patients.

Brett E. Skolnick, PhD, Lisa Payne Rojkjaer, MD, Stephanie V. Seremetis, MD
Journal: Blood
Blood (2004) 104 (11): 3978.
https://doi.org/10.1182/blood.V104.11.3978.3978
Published: 2004